HeyJaredMark Leiser
- Indexed articles, last 90 days
- 40
- Latest publication
- Oct 1, 2026
- Outlet visibility, for Healio
- Top 500K sites
- Earliest in this view
- Jul 6, 2026
Latest articles
Noninvasive procedure âlife changingâ for people with treatment-resistant major depression (opens the original)
Read excerpt
A noninvasive neurosurgical procedure that delivers radiation to a specific brain pathway significantly reduced symptoms of major depression among people with severe, treatment-resistant psychiatric illness, study results showed. Stereotactic radiosurgical (SRS) capsulotomy also led to a significant reduction in suicidal ideation, findings from a prospective observational study presented at ASTRO Annual Meeting showed. “Patients had remarkable, life-changing improvements — and, given the resolut
HHS launches initiatives designed to make clinical trials faster, more efficient (opens the original)
Read excerpt
HHS launched a multi-component effort intended to improve the speed and efficiency with which clinical trials are conducted. The series of initiatives is designed to eliminate duplication, ensure more efficient enrollment and provide patients with earlier access to promising therapies. “The goal is straightforward — generate rigorous evidence faster, reduce unnecessary costs and burdens, and make the United States the best place in the world to engage in clinical trial research,” HHS Secretary R
1 in 8 cancers attributable to infections; burden âenormousâ but âlargely preventableâ (opens the original)
Read excerpt
More than 2 million new cancers diagnosed worldwide in 2024 could be attributable to infections, according to study findings. This equates to about one of every eight cases. âWhile this burden is enormous, it is also largely preventable,â lead author Harriet Rumgay, PhD, an epidemiologist in the International Agency for Research on Cancerâs (IARC) cancer surveillance branch, told Healio. âWe already have effective tools and public health strategies that can prevent many infection-related
âTime to actâ: Signals that GLP-1s reduce cancer risk strengthen; prospective study planned (opens the original)
Read excerpt
More than a dozen studies presented at ASCO Annual Meeting added to a growing volume of research that suggests GLP-1 receptor agonists may protect against several types of cancer. However, as evidence mounts, so do reminders that findings have emerged entirely from database-driven retrospective cohort studies, which are prone to systematic biases and cannot prove causality. âThe signal is as strong as it has ever been â and probably as strong as it will ever be â but we are still talking a
Sustained investment in âmeritoriousâ research key to continued progress against cancer (opens the original)
Read excerpt
Advances in genomic medicine and a deeper understanding of how to harness the immune system continue to allow for more precise therapies that improve outcomes for people with cancer, according to a new report. The American Association for Cancer Researchâs Cancer Progress Report 2026 highlights how basic, clinical and translational breakthroughs have helped reduce cancer mortality by more than one-third since 1991, with particularly notable survival improvements among individuals with advanced
Publishing over time
Last 90 days. Choose a month to open its work.
Recurring subjects
Named in the text we hold. One piece can cover several.
Audience
Top 500K sites
For Healio, the outlet · Measured Aug 1, 2026
Website popularity band, not a count of readers or article views.
About this data
Counts cover the work we have indexed. Tone needs enough text and a confident classification. Excerpts and episode notes are not full articles or transcripts.
Identity or attribution wrong? Suggest a correction.